Sigma Investment Counselors’s iShares Biotechnology ETF IBB Stock Holding History

Sigma Investment Counselors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,357	Closed	-$207K	–	195
2021 Q4	$207K	Sell	1,357 -32	-2%	-$4.95K	0.01%	192
2021 Q3	$225K	Buy	1,389 +20	+1%	+$3.37K	0.02%	179
2021 Q2	$224K	Buy	+1,369	New	+$211K	0.02%	182

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sigma Investment Counselors's IBB Position: Q1 2022 in Review

Sigma Investment Counselors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 1,357 shares — an estimated $207K sold.

Sigma Investment Counselors first reported a position in IBB in Q2 2021 and held it in 3 quarters. The position peaked at $225K in Q3 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Sigma Investment Counselors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Sigma Investment Counselors sold 1,357 iShares Biotechnology ETF shares in Q1 2022, an estimated $207K.
Sigma Investment Counselors first reported a position in iShares Biotechnology ETF in Q2 2021 and held it in 3 quarters.
Sigma Investment Counselors's iShares Biotechnology ETF position peaked at $225K in Q3 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Sigma Investment Counselors's 13F filing for Q1 2022, filed 20 Apr 2022.